Topic

Signifor / Signifor LAR (pasireotide)

A collection of 32 issues

Lowering Out-of-Pocket for Signifor / Signifor LAR (pasireotide) with UnitedHealthcare in New Jersey: Copay, Tiering & Assistance

Quick Answer: Reducing Your Signifor LAR Costs with UnitedHealthcare in New Jersey UnitedHealthcare requires prior authorization for Signifor LAR (pasireotide) with potential high specialty tier costs. Key cost-reduction strategies include the manufacturer's $20 copay program for commercial insurance, foundation grants up to $13,600/year, and formulary tier
6 min read

How to Get Signifor / Signifor LAR (pasireotide) Covered by Cigna in Illinois: Prior Authorization, Appeals & Step Therapy Guide

Answer Box: Getting Signifor/Signifor LAR Covered by Cigna in Illinois Cigna requires prior authorization for all Signifor/Signifor LAR (pasireotide) prescriptions in Illinois. For acromegaly, you must first try octreotide or lanreotide; for Cushing's disease, document surgical failure or ineligibility. Your endocrinologist must submit detailed clinical evidence
5 min read

How to Get Signifor LAR (Pasireotide) Covered by Humana in Michigan: PA Forms, Appeals Timeline & Cost-Saving Strategies

Quick Answer: Getting Signifor LAR Covered by Humana in Michigan Signifor LAR (pasireotide) requires prior authorization from Humana for both Cushing's disease and acromegaly treatment. The fastest path to approval involves your endocrinologist submitting comprehensive biochemical documentation—elevated 24-hour urinary free cortisol (UFC) for Cushing's or
6 min read